pancreastatin Inhibitors
Pancreastatin inhibitors are a class of chemical compounds that target pancreastatin, a regulatory peptide derived from chromogranin A, a protein found in the secretory vesicles of neuroendocrine cells. Pancreastatin is known to play a role in various metabolic processes, particularly in modulating glucose metabolism, lipid metabolism, and insulin signaling. It acts by binding to specific receptors on target cells and influencing downstream signaling pathways that control cellular metabolism. By inhibiting pancreastatin, these compounds interfere with its regulatory effects on metabolic homeostasis, providing insights into how this peptide modulates biochemical pathways at the cellular level.
Pancreastatin inhibitors work by binding to pancreastatin or its receptors, thereby preventing the peptide from exerting its influence on cellular signaling. This disruption can alter the regulatory circuits governing energy balance, glucose utilization, and lipid storage, which are processes crucial to maintaining metabolic equilibrium. These inhibitors offer valuable tools for researchers investigating the molecular pathways through which pancreastatin regulates metabolism. By blocking pancreastatin's activity, scientists can study its role in controlling insulin sensitivity, lipid breakdown, and the production of glucose. Such investigations deepen our understanding of the complex interplay between hormones, peptides, and metabolic enzymes, offering insights into the mechanisms that control energy balance and metabolic regulation at both the cellular and organismal levels.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may downregulate pancreastatin expression by increasing the acetylation of histones associated with the chromogranin A gene, leading to a tighter chromatin structure and reduced transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could decrease pancreastatin levels by promoting the demethylation of DNA sequences upstream of the chromogranin A gene, reducing its expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could reduce pancreastatin expression by inhibiting mTOR signaling, which may decrease the overall protein synthesis machinery available for chromogranin A production, thereby lowering pancreastatin synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and impedes the elongation phase of RNA synthesis; this action may decrease transcription levels of the chromogranin A gene, resulting in diminished pancreastatin production. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide may halt pancreastatin production by blocking the translocation step in protein synthesis, which would inhibit the elongation of the chromogranin A peptide chain, thus reducing pancreastatin levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may decrease pancreastatin expression by inhibiting the MAP kinase pathway, which could lead to reduced activation of transcription factors necessary for the expression of the chromogranin A gene. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
The inhibition of p38 MAP kinase by SB 203580 could reduce the expression of stress-induced proteins, potentially leading to a decrease in chromogranin A gene activation and thus lower pancreastatin levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may reduce pancreastatin expression by inhibiting PI3K, which could lead to decreased activation of downstream pathways like AKT, influencing the transcriptional control of the chromogranin A gene. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin may lead to a decrease in pancreastatin levels by inhibiting PI3K and disrupting downstream signaling pathways that contribute to the transcription and translation processes involved in chromogranin A production. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
By inhibiting JNK, SP600125 could decrease transcriptional activation of the chromogranin A gene, which would result in lower expression levels of pancreastatin. | ||||||